Evidence map›Paper›PMID 32732692›Full record

ArticleThe American Journal of dermatopathology2020

Desmoplastic Melanomas Mimicking Neurofibromas.

Pedram Gerami, Daniel Kim, Bin Zhang, Elsy V Compres, Ayesha U Khan, Pedram Yazdan, Joan Guitart, Klaus Busam

Abstract readMulticenter Study
In one paragraph

Article in The American Journal of dermatopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Desmoplastic Melanoma of the Chest Wall: a Diagnostic Dilemma.Indian journal of surgical oncology · 2024
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pedram GeramiDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Daniel KimDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Bin ZhangDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Elsy V CompresDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Ayesha U KhanDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Pedram YazdanDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Joan GuitartDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Klaus BusamDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Desmoplastic melanoma can be difficult to diagnose and on average have a significantly higher T stage at the time of diagnosis compared with conventional melanomas. Histologically, these tumors typically consist of spindle cells in a fibrous matrix. The spindle cells may display fibroblast and/or Schwann cell-like features. In this study, we describe the features of 12 cases of desmoplastic melanoma closely simulating neurofibroma. Although the spindle cells in these tumors may be indistinguishable from those of neurofibroma, features such as prominent fibroplasia (12/12), poor lateral circumscription (8/9), diffuse infiltration of subcutaneous tissue (7/9), and lymphoid aggregates (10/12) may be helpful clues to the diagnosis. No immunohistochemical markers were reliable in distinguishing neurofibroma-like desmoplastic melanomas from neurofibroma. Clinical follow-up was available in 8 cases, of which 4 were initially misdiagnosed as benign neoplasms and given no further re-excision. All 4 of these cases recurred; 2 of which showed transformation to a more aggressive phenotype.

Indexed as

AdultAgedAged, 80 and overAntigens, NeoplasmBiomarkers, TumorBiopsyDiagnosis, DifferentialDiagnostic ErrorsFemaleHumansIllinoisImmunohistochemistryIntermediate FilamentsMaleMelanomaMiddle AgedAntigens, NeoplasmBiomarkers, TumorPRAME protein, humanTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID32732692
PMCPMC10117406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.